EE Impact

Abbott Laboratories

USA · Pharma & Healthcare

Also known as: Abbot Labs; Abbott Labs

LeaveRussia detail: Pausing Investments

Operations suspended
Global 500Top 100

Abbott Laboratories is an American multinational medical devices and health care company. It sells medical devices, diagnostics, branded generic medicines and nutritional products.

Status last verified 03/08/2026Source checked 29/08/2024Company website ↗LeaveRussia profile ↗

Business in Russia

Pharmaceutical production. There have been problems with the import of products for the treatment of diabetes.

Decision trail

Decision date 29/04/2022 · Reference ↗

The company suspends non-essential business activity in the country, including all new investments, business development and advertising. So far, the only product (treatment of diabetes) left on the Russian market is the American Abbott.

Local stats (LeaveRussia)

Assets(RF), mln.USD
587
Capital(RF), mln.USD
445
Glob.Revenue, mln.USD
40109
Offices
2
Plants
3
Revenue(RF), mln.USD
670
Staff(RF), 2021
721
Taxes(RF), mln.USD
120

Status history since 2022

  1. 03/08/2026 suspended · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.